{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:25:05Z","timestamp":1787495105567,"version":"build-2736575974"},"reference-count":45,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Capricor Therapeutics, Inc.","award":["CAPR"],"award-info":[{"award-number":["CAPR"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Duchenne muscular dystrophy (DMD) is characterized by progressive skeletal and cardiac muscle degeneration driven by inflammation and fibrosis, ultimately leading to cardiomyopathy and premature death. Deramiocel, an allogeneic cell therapy composed of cardiosphere-derived cells (CDCs), has demonstrated potent anti-fibrotic and immunomodulatory effects in preclinical models and clinical trials, including HOPE-2 and its open-label extension (HOPE-2 OLE), where Deramiocel treatment significantly attenuated progression of skeletal and cardiac muscle dysfunction. Methods: CDCs in Deramiocel were cultured to generate CM enriched with secreted exosomes and factors, which was subsequently applied to primary human dermal fibroblasts (HDFs). Following co-culture, ex-pression of collagen type I alpha 1 (COL1A) and collagen type III alpha 1 (COL3A) was measured by qRT-PCR. Non-conditioned media serves as a control in the assay. Reduction in COL1A and COL3A expression therefore provides a direct and clinically relevant measure of the anti-fibrotic activity of Deramiocel. Results: A novel in vitro potency assay was developed to quantify the anti-fibrotic activity of Deramiocel. Conditioned media (CM) from over one hundred Deramiocel manufacturing lots significantly suppressed expression of collagen type I alpha 1 (COL1A) and collagen type III alpha 1 (COL3A) in primary human dermal fibroblasts compared with non-conditioned media controls, establishing a robust, reproducible readout of anti-fibrotic activity. The effect was dose-dependent and abrogated by sequential depletion of exosomes and soluble proteins, implicating both as critical mediators of Deramiocel\u2019s mechanism of action. Importantly, CDCs in Deramiocel lots classified as potent by this assay were shown to exert a clinically meaningful benefit in DMD patients in the HOPE-2 and HOPE-2 OLE studies. Conclusions: This assay represents a mechanistically informative, therapeutically relevant, reproducible, scalable, and regulatory-compliant approach for assessing Deramiocel potency, enabling consistent manufacturing, and facilitating the continued development of Deramiocel as a disease-modifying therapy for DMD.<\/jats:p>","DOI":"10.3390\/biomedicines13112652","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:16:24Z","timestamp":1761729384000},"page":"2652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Novel In Vitro Potency Assay Demonstrating the Anti-Fibrotic Mechanism of Action of CDCs in Deramiocel"],"prefix":"10.3390","volume":"13","author":[{"given":"Yujia","family":"Li","sequence":"first","affiliation":[{"name":"Capricor Therapeutics, Inc., 10865 Road to the Cure, San Diego, CA 92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Nice","sequence":"additional","affiliation":[{"name":"Capricor Therapeutics, Inc., 10865 Road to the Cure, San Diego, CA 92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3797-9772","authenticated-orcid":false,"given":"Marya","family":"Kozinova","sequence":"additional","affiliation":[{"name":"Capricor Therapeutics, Inc., 10865 Road to the Cure, San Diego, CA 92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Adachi","sequence":"additional","affiliation":[{"name":"Capricor Therapeutics, Inc., 10865 Road to the Cure, San Diego, CA 92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Marb\u00e1n","sequence":"additional","affiliation":[{"name":"Capricor Therapeutics, Inc., 10865 Road to the Cure, San Diego, CA 92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Elliott","sequence":"additional","affiliation":[{"name":"Capricor Therapeutics, Inc., 10865 Road to the Cure, San Diego, CA 92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1756-6506","authenticated-orcid":false,"given":"Minghao","family":"Sun","sequence":"additional","affiliation":[{"name":"Capricor Therapeutics, Inc., 10865 Road to the Cure, San Diego, CA 92121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e033862","DOI":"10.1161\/JAHA.123.033862","article-title":"Cardiac histopathology in Duchenne muscular dystrophy demonstrates diffuse fibrofatty replacement of the myocardium","volume":"13","author":"Breaux","year":"2024","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_2","first-page":"e010040","article-title":"Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy","volume":"16","author":"Soslow","year":"2023","journal-title":"Circ. Hear. Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jacbts.2016.01.003","article-title":"Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation","volume":"1","author":"Gallet","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2015.05.068","article-title":"Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles","volume":"66","author":"Tseliou","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rogers, R.G., Li, L., Peck, K., Sanchez, L., Liu, W., Ciullo, A., Alfaro, J., Rannou, A., Fournier, M., and Lee, Y. (2021). Cardiosphere-derived cells, with and without a biological scaffold, stimulate myogenesis and recovery of muscle function in mice with volumetric muscle loss. Biomaterials, 274.","DOI":"10.1016\/j.biomaterials.2021.120852"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.mayocp.2014.02.014","article-title":"Breakthroughs in cell therapy for heart disease: Focus on cardiosphere-derived cells","volume":"89","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CRD.0000000000000173","article-title":"Cardiosphere-Derived Cells and Ischemic Heart Failure","volume":"26","author":"Ashur","year":"2018","journal-title":"Cardiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.stemcr.2018.01.023","article-title":"Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy","volume":"10","author":"Aminzadeh","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e125754","DOI":"10.1172\/jci.insight.125754","article-title":"Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice","volume":"4","author":"Rogers","year":"2019","journal-title":"JCI Insight"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/febs.12267","article-title":"The mdx mouse model as a surrogate for Duchenne muscular dystrophy","volume":"280","author":"Partridge","year":"2013","journal-title":"FEBS J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(22)00012-5","article-title":"Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"399","author":"McDonald","year":"2022","journal-title":"Lancet"},{"key":"ref_14","unstructured":"McDonald, C.M., Villa, C., Soslow, J.H., Tian, C., Zygmunt, A.M., Ollberding, N.J., Hor, K.N., Harmelink, M.M., Varadhachary, A.S., and Apkon, S. (2024, January 8\u201312). Multi-modal benefits of deramiocel (CAP-1002) in late-stage patients with Duchenne muscular dystrophy: HOPE-2-OLE trial\u201436-month data. Proceedings of the 29th Annual International Congress of the World Muscle Society (WMS 2024), Vancouver, BC, Canada. Available online: https:\/\/d1io3yog0oux5.cloudfront.net\/_958553a36c8534969b6e9dd543064101\/capricor\/files\/pages\/our-science\/publications\/WMS_2024_Poster_%28Capricor%29.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e12178","DOI":"10.1002\/jev2.12178","article-title":"Biodistribution of unmodified cardiosphere-derived cell extracellular vesicles using single RNA tracing","volume":"11","author":"Ciullo","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_18","first-page":"201","article-title":"Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction","volume":"38","author":"Gallet","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","article-title":"Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells","volume":"59","author":"Li","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e001260","DOI":"10.1161\/JAHA.114.001260","article-title":"Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction","volume":"3","author":"Cheng","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.matbio.2005.12.002","article-title":"Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts","volume":"25","author":"Mimura","year":"2006","journal-title":"Matrix Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhu, J., Wang, S., Yang, D., Xu, W., and Qian, H. (2023). Extracellular vesicles: Emerging roles, biomarkers and therapeutic strategies in fibrotic diseases. J. Nanobiotechnol., 21.","DOI":"10.1186\/s12951-023-01921-3"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Farooq, M., Khan, A.W., Kim, M.S., and Choi, S. (2021). The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration. Cells, 10.","DOI":"10.3390\/cells10113242"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103143","DOI":"10.1016\/j.isci.2021.103143","article-title":"Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis","volume":"24","author":"Fearon","year":"2021","journal-title":"iScience"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41374-018-0049-0","article-title":"Heparin-binding epidermal growth factor contributes to COPD disease severity by modulating airway fibrosis and pulmonary epithelial-mesenchymal transition","volume":"98","author":"Lai","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e92192","DOI":"10.1172\/jci.insight.92192","article-title":"Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis","volume":"2","author":"Murray","year":"2017","journal-title":"JCI Insight"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.7150\/thno.19435","article-title":"Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells","volume":"7","author":"Kanda","year":"2017","journal-title":"Theranostics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jcp.24613","article-title":"Interleukin-6 contributes to the paracrine effects of cardiospheres cultured from human, murine and rat hearts","volume":"229","author":"Maxeiner","year":"2014","journal-title":"J. Cell Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Husebye, T., Eritsland, J., Arnesen, H., Bj\u00f8rnerheim, R., Mangschau, A., Seljeflot, I., and Andersen, G.\u00d8. (2014). Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112359"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1242\/jcs.082271","article-title":"Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity","volume":"124","author":"Privratsky","year":"2011","journal-title":"J. Cell Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"H1056","DOI":"10.1152\/ajpheart.00459.2021","article-title":"Guidelines for in vivo mouse models of myocardial infarction","volume":"321","author":"Lindsey","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Spurney, C.F., Cha, H.-J., Sali, A., Pandey, G.S., Pistilli, E., Guerron, A.D., Gordish-Dressman, H., Hoffman, E.P., and Nagaraju, K. (2010). Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin \u03b2-4 in the Dystrophin Deficient Mouse. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008976"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zubkova, E., Dergilev, K., Beloglazova, I., Kalinin, A., Guseva, A., Andreev, A., Partigulov, S., Lepilin, M., Menshikov, M., and Parfyonova, Y. (2023). Paracrine Responses of Cardiosphere-Derived Cells to Cytokines and TLR Ligands: A Comparative Analysis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417278"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Femmin\u00f2, S., Bonelli, F., and Brizzi, M.F. (2022). Extracellular vesicles in cardiac repair and regeneration: Beyond stem-cell-based approaches. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.996887"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00395-022-00913-y","article-title":"Uncovering the molecular identity of cardiosphere-derived cells (CDCs) by single-cell RNA sequencing","volume":"117","author":"Kogan","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Feng, Y., Huang, W., Wani, M., Yu, X., and Ashraf, M. (2014). Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088685"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Weber, B., Sturm, R., Henrich, D., Lupu, L., Rottluff, K., Marzi, I., and Leppik, L. (2023). Diagnostic and Prognostic Potential of Exosomal Cytokines IL-6 and IL-10 in Polytrauma Patients. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411830"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"113424","DOI":"10.1016\/j.celrep.2023.113424","article-title":"Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8+ T cell","volume":"42","author":"Xu","year":"2023","journal-title":"Cell Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.18632\/aging.202466","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1\/TRAF6 signaling pathway after ischemic stroke","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","article-title":"Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages","volume":"13","author":"Tian","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rogers, R.G., Ciullo, A., Marb\u00e1n, E., and Ibrahim, A.G. (2020). Extracellular Vesicles as Therapeutic Agents for Cardiac Fibrosis. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00479"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:15:29Z","timestamp":1761732929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["biomedicines13112652"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13112652","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.09.18.675440","asserted-by":"object"}]},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}